230 related articles for article (PubMed ID: 6858782)
21. Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
Jellinger K
J Neurol; 1982; 227(2):75-88. PubMed ID: 6180142
[TBL] [Abstract][Full Text] [Related]
22. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
[TBL] [Abstract][Full Text] [Related]
23. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
24. [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
Rascol A; Montastruc JL; Guiraud-Chaumeil B; Clanet M
Rev Neurol (Paris); 1982; 138(5):401-8. PubMed ID: 7146724
[TBL] [Abstract][Full Text] [Related]
25. [Pergolide mesylate in the treatment of Parkinson's disease resistant to other treatments. First Italian experience].
Pezzoli G; Zecchinelli A; Mariani C; Reganati P; Scarlato G
Clin Ter; 1991 Jan; 136(1):39-45. PubMed ID: 1826872
[TBL] [Abstract][Full Text] [Related]
26. The use of pergolide, a potent dopamine agonist, in Parkinson's disease.
Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Walker R; Pact V
Clin Pharmacol Ther; 1982 Jul; 32(1):70-5. PubMed ID: 7083733
[TBL] [Abstract][Full Text] [Related]
27. A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease.
Klawans HL; Tanner CM; Glatt S; Goetz CG
Adv Neurol; 1983; 37():75-83. PubMed ID: 6344592
[No Abstract] [Full Text] [Related]
28. Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study.
van der Drift JH
Adv Neurol; 1987; 45():529-34. PubMed ID: 3825731
[TBL] [Abstract][Full Text] [Related]
29. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
Linazasoro G;
J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
[TBL] [Abstract][Full Text] [Related]
30. Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.
Lucetti C; Gambaccini G; Del Dotto P; Ceravolo R; Logi C; Rossi G; Murri L; Bonuccelli U
Parkinsonism Relat Disord; 2006 Jun; 12(5):279-83. PubMed ID: 16549382
[TBL] [Abstract][Full Text] [Related]
31. Dopamine agonists in the treatment of Parkinson's disease.
Rinne UK
Adv Neurol; 1983; 37():141-50. PubMed ID: 6305175
[TBL] [Abstract][Full Text] [Related]
32. Comparison between lergotrile and bromocriptine in parkinsonism.
Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
[TBL] [Abstract][Full Text] [Related]
33. The addition of bromocriptine to long-term dopa therapy in Parkinson's disease.
Selby G
Clin Exp Neurol; 1989; 26():129-39. PubMed ID: 2701877
[TBL] [Abstract][Full Text] [Related]
34. Long-term treatment with pergolide: decreased efficacy with time.
Lieberman AN; Goldstein M; Leibowitz M; Gopinathan G; Neophytides A; Hiesiger E; Nelson J; Walker R
Neurology; 1984 Feb; 34(2):223-6. PubMed ID: 6538014
[TBL] [Abstract][Full Text] [Related]
35. Further studies with pergolide in Parkinson disease.
Lieberman AN; Goldstein M; Gopinathan G; Leibowitz M; Neophytides A; Walker R; Hiesiger E; Nelson J
Neurology; 1982 Oct; 32(10):1181-4. PubMed ID: 6889703
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of pergolide and mesulergine.
Lieberman AN; Gopinathan G; Neophytides A
Eur Neurol; 1986; 25(2):86-90. PubMed ID: 3948891
[TBL] [Abstract][Full Text] [Related]
37. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.
Olanow CW; Fahn S; Muenter M; Klawans H; Hurtig H; Stern M; Shoulson I; Kurlan R; Grimes JD; Jankovic J
Mov Disord; 1994 Jan; 9(1):40-7. PubMed ID: 8139604
[TBL] [Abstract][Full Text] [Related]
38. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
[TBL] [Abstract][Full Text] [Related]
39. [Lisuride in the combination treatment of Parkinson disease].
Jellinger K
Wien Med Wochenschr; 1987 Apr; 137(7-8):155-9. PubMed ID: 3111099
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of parkinsonian syndromes by bromocriptin].
Gautier JC; Durand JP
Nouv Presse Med; 1977 Jan; 6(3):171-4. PubMed ID: 319421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
